MedTrace Logo

Ultrasound Guided Spinal Anesthesia in Non Obese Obstetric Patients

NCT01440400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-03-12

No results posted yet for this study

Summary

The classical method for spinal anesthesia relies on the use of bony landmarks to identify the level and point of entry of the spinal needle. Over the years, in experienced hands, this method consistently proved to be successful and safe.

The introduction of ultrasound to guide neuraxial anaesthesia into clinical practice was relatively slow compared to peripheral nerve blocks or central venous catheterization. This could be due to the technical difficulties posed by the bony structures surrounding the spinal cord and its dura that blocks the path of the ultrasound beam. Many anesthetists are reluctant to change their conventional landmark technique, particularly with most studies showing no change in the success rate between ultrasound guided and the landmark techniques.

Several studies however showed that the ultrasound guided approach reduces the number of attempts to achieve a successful block and reduces the procedure time particularly in obese patients and those with technical difficulties.

In this study the investigators are trying to answer the following question : Is there any advantage in using ultrasound to guide spinal anaesthesia in non obese obstetric patients with easily palpable bony landmarks?

Conditions

  • Cesarean Section

Interventions

PROCEDURE

Ultrasound guided spinal anesthesia

Using the ultrasound to identify the spinal puncture level, mid-line and the depth of the dura.

Sponsors & Collaborators

  • Corniche Hospital

    lead OTHER

Principal Investigators

  • Tarek Ansari, FFARCSI · Corniche Hospital

  • Mounir Fayez, MD · Corniche Hospital

  • Amr Maher, MD · Corniche Hospital

  • Ahmed El Gamassy, MD · Corniche Hospital

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-07-31
Completion
2012-10-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01440400 on ClinicalTrials.gov